Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venoglobulin-IH in systemic sclerosis
NCT00348296Phase 3Completed
- Start
- Jul 2006
- Primary completion
- Jul 2009
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of intravenous immunoglobulin G in systemic sclerosis (SSc). Primary endpoint: modified Rodnan total skin thickness score at 12 weeks. Started Jul 2006; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00348296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348296.